Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque

Biochemical and Biophysical Research Communications

Volumn 366, Issue 4, 2008, Pages 871-877

  Dandapat, Abhijit ^a   Hu, Chang Ping ^a,b   Chen, Jiawei ^a   Liu, Yong ^a   Khan, Junaid A ^a   Remeo, Francesco ^c   Carey, Robert M ^d   Hermonat, Paul L ^a   Mehta, Jawahar L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Angiotensin II; Atherosclerosis; Collagen; Matrix metalloproteinases; Receptors

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CHLORDANE; COLLAGEN; FIBRONECTIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPONTIN; PROCOLLAGEN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS TYPE 2; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CHOLESTEROL DIET; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HYPOTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; AORTA; ATHEROSCLEROSIS; COLLAGEN; FIBRONECTINS; GENE EXPRESSION; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOPONTIN; OXIDANTS; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; UP-REGULATION;

ADENO-ASSOCIATED VIRUS - 2; MUS;

EID: 37549029151     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.061     Document Type: Article

References (38)

1. Steinberg D. Lipoproteins and the pathogenesis of atherosclerosis. Circulation 76 (1987) 508-514
2. Pennathur S., and Heinecke J.W. Oxidative stress and endothelial dysfunction in vascular disease. Curr. Diab. Rep. 7 (2007) 257-264
3. Libby P. Inflammatory and immunomechanism in atherogenesis. Atheroscler. Rev. 21 (1990) 79-89
4. Schulze P.C., and Lee R.T. Oxidative stress and atherosclerosis. Curr. Atheroscler. Rep. 7 (2005) 242-248
5. Kunz J. Matrix metalloproteinases and atherogenesis in dependence of age. Gerontology 53 (2007) 63-73
6. Mehta P.K., and Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292 (2007) C82-C97
7. Chen J., Li D., Schaefer R., and Mehta J.L. Cross-talk between dyslipidemia andi renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis 184 (2006) 295-301
8. Carey R.M. Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 45 (2005) 840-884
9. Falcon B.L., Stewart J.M., Bourassa E., Katovich M.J., Walter G., Speth R.C., Sumners C., and Raizada M.K. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol. Genomics 19 (2004) 255-261
10. Masaki H., Kurihara T., Yamaki A., Inomata N., Nozawa Y., Mori Y., Murasawa S., Kizima K., Maruyama K., Horiuchi M., Dzau V.J., Takahashi H., Iwasaka T., Inada M., and Matsubara H. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor mediated pressor and chronotropic effects. J. Clin. Invest. 101 (1998) 527-535
11. Gross V., Obst M., Kiss E., Janke J., Mazak I., Shagdarsuren E., Muller D.N., Langenickel T.H., Grone H.J., and Luft F.C. Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice. J. Hypertens. 22 (2004) 997-1005
12. Voros S., Yang Z., Bove C.M., Gilson W.D., Epstein F.H., French B.A., Berr S.S., Bishop S.P., Conaway M.R., Matsubara H., Carey R.M., and Kramer C.M. Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1004-H1010
13. Iwai M., Chen R., Li Z., Shiuchi T., Suzuki J., Ide A., Tsuda M., Okumura M., Min L.J., Mogi M M., and Horiuchi M. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112 (2005) 1636-1643
14. Sales V.L., Sukhova G.K., Lopez-Ilasaca M.A., Libby P., Dzau V.J., and Pratt R.E. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 112 (2005) 3328-3336
15. Wu L., Iwai M., Nakagami H., Chen R., Suzuki J., Akishita M., de Gasparo M., and Horiuchi M. Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 49-54
16. Hutchinson H.G., Hein L., Fujinaga M., and Pratt R.E. Modulation of vascular development and injury by angiotensin II. Cardiovasc. Res. 41 (1999) 689-700
17. C.P. Hu, A. Dandapat, J. Chen, Y. Liu, P.L. Hermonat, R.M. Carey, J.L. Mehta, Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression, Atherosclerosis, in press.
18. Li D., Liu Y., Chen J., Velchala N., Amani F., Nemarkommula A., Chen K., Rayaz H., Zhang D., Liu H., Sinha A.K., Romeo F., Hermonat P.L., and Mehta J.L. Suppression of atherogenesis by delivery of TGFβ1ACT using adeno-associated virus type 2 in LDLR knockout mice. Biochem. Biophys. Res. Commun. 344 (2006) 701-707
19. Mehta J.L., Sanada N., Hu C.P., Chen J., Dandapat A., Sugawara F., Satoh H., Inoue K., Kawase Y., Jishage K., Suzuki H., Takeya M., Schnackenberg L., Beger R., Hermonat P.L., Thomas M., and Sawamura T. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ. Res. 100 (2007) 1634-1642
20. Bruemmer D., Collins A.R., Noh G., Wang W., Territo M., Arias-Magallona S., Fishbein M.C., Blaschke F., Kintscher U., Graf K., Law R.E., and Hsueh W.A. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J. Clin. Invest. 112 (2003) 1318-1331
21. Paoletti F., and Mocali A. Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells. Cancer Res. 48 (1988) 6674-6677
22. Arbustini E., and Roberts W.C. Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease). Am. J. Cardiol. 78 (1996) 814-820
23. Gojova A., Brun V., Esposito B., Cottrez F., Gourdy P., Ardouin P., Tedgui A., Mallat Z., and Groux H. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102 (2003) 4052-4058
24. Collins A.R., Schnee J., Wang W., Kim S., Fishbein M.C., Bruemmer D., Law R.E., Nicholas S., Ross R.S., and Hsueh W.A. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J. Am. Coll. Cardiol. 43 (2004) 1698-1705
25. Chen K K., Mehta J.L., Li D., Joseph L., and Joseph J. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res. 95 (2004) 1167-1173
26. Chen H., Li D., and Mehta J.L. Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 39 (2002) 332-339
27. Stocker R., and Keaney Jr. J.F. New insights on oxidative stress in the artery wall. J. Thromb. Haemost. 3 (2005) 1825-1834
28. Thomas M., Gavrila D., McCormick M.L., Miller Jr. J.F., Daugherty A., Cassis L.A., Dellsperger K.C., and Weintraub N.L. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114 (2006) 404-413
29. Chen K., Chen J., Li D., Zhang X., and Mehta J.L. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44 (2004) 655-661
30. Bataller R., Gabele E., Schoonhoven R., Morris T., Lehnert M., Yang L., Brenner D.A., and Rippe R.A. Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and pro-inflammatory events in liver. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G642-G651
31. Masutomo K., Makino N., and Fushiki M.S. Effects of losartan on the collagen degradative enzymes in hypertrophic and congestive types of cardiomyopathic hamsters. Mol. Cell Biochem. 224 (2001) 19-27
32. Xie Z., Singh M., and Singh K. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J. Cell Physiol. 198 (2004) 399-407
33. Lai C.F., Seshadri V., Huang K., Shao J.S., Cai J., Vattikuti R., Schumacher A., Loewy A.P., Denhardt D.T., Rittling S.R., and Towler D.A. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ. Res. 98 (2006) 1479-1489
34. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., and Abboud H.E. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280 (2005) 39616-39626
35. Clerk A., and Sugden P.H. Inflame my heart (by p38-MAPK). Circ. Res. 99 (2006) 455-458
36. Vaziri N.D., Xu Z.G., Shahkarami A., Huang K.T., Rodriguez-Iturbe B., and Natarajan R. Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Kidney Int. 68 (2005) 2787-2793
37. Chen J., and Mehta J.L. Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1738-H1745
38. Naito T., Masaki T., Nikolic-Paterson D.J., Tanji C C., Yorioka N., and Kohno N. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am. J. Physiol. Renal Physiol. 286 (2004) 278-287